abstract |
The subject matter of the present invention is directed to novel substituted beta-carbolines, and specifically compounds of the formula I, n nwhich are suitable for the production of pharmaceuticals for the prophylaxis and therapy of disorders in whose course an increased activity of IκB kinase is involved. |